Skip to main content
Top
Published in: Cancer and Metastasis Reviews 1-2/2019

01-06-2019 | Correction

Correction to: mTOR co-targeting strategies for head and neck cancer therapy

Authors: Zhiyong Wang, Juan Callejas Valera, Xuefeng Zhao, Qianming Chen, J. Silvio Gutkind

Published in: Cancer and Metastasis Reviews | Issue 1-2/2019

Login to get access

Excerpt

Correction to: Cancer Metastasis Rev (2017) 36:491–502
Metadata
Title
Correction to: mTOR co-targeting strategies for head and neck cancer therapy
Authors
Zhiyong Wang
Juan Callejas Valera
Xuefeng Zhao
Qianming Chen
J. Silvio Gutkind
Publication date
01-06-2019
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 1-2/2019
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-018-9765-6

Other articles of this Issue 1-2/2019

Cancer and Metastasis Reviews 1-2/2019 Go to the issue

EditorialNotes

Preface

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine